Matching the right drug to the right patient in essential hypertension

Heart

Volumn 86, Issue 1, 2001, Pages 113-120

  Brown, M J ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; THIAZIDE DIURETIC AGENT;

DRUG CONTRAINDICATION; DRUG INDICATION; DRUG MECHANISM; HUMAN; HYPERTENSION; LONG TERM CARE; PATHOGENESIS; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING;

ADRENERGIC BETA-ANTAGONISTS; AGE FACTORS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; CEREBROVASCULAR ACCIDENT; DIURETICS; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION; MIDDLE AGED; MODELS, CARDIOVASCULAR; MYOCARDIAL ISCHEMIA; PATIENT SELECTION; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 0034765196     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
2. Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias
3. Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context
4. British Hypertension Society guidelines for hypertension management 1999: Summary
5. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham heart study
6. Influence of age on general practitioners' definition and treatment of hypertension
7. Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: The Nordic diltiazem (NORDIL) study
8. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The captopril prevention project (CAPPP) randomised trial
9. Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity. The Swedish trial in old patients with hypertension-2 study
10. Morbidity and mortality in patients randomised to double-blind treatment with once-daily calcium channel blockade or diuretic in the International nifedipine GITS study: Intervention as a goal in hypertension treatment (INSIGHT)
11. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
12. Effects of angiotensin converting enzyme inhibitors, calcium antagonists and other blood pressure lowering drugs on mortality and major cardiovascular morbidity
13. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
14. Optimisation of anti-hypertensive treatment by crossover rotation of four major classes
15. Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the treatment of mild hypertension study
16. The hypertension optimal treatment study and the importance of lowering blood pressure
17. Prevention of dementia in randomised double-blind placebo-controlled systolic hypertension in Europe (Syst-Eur) trial
18. Clinical practice recommendations 2000
19. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
20. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the hypertension optimal treatment (HOT) randomised trial
21. Abandoning diastole
22. Renin profiling for diagnosis and treatment of hypertension
23. Antihypertensive beta blocking action as related to renin and age: A pharmacologic tool to identify pathogenetic mechanisms in essential hypertension
24. A genome-wide search for susceptibility loci to human essential hypertension
25. Within-patient correlation between the antihypertensive effects of atenolol, lisinopril and nifedipine
26. Diagnosis ex juvantibus. Individual response patterns to drugs reveal hypertension mechanisms and simplify treatment
27. Crossover design to test antihypertensive drugs with self-recorded blood pressure
28. Individual responses to converting enzyme inhibitors and calcium antagonists
29. Double-blind, placebo-controlled crossover rotation of the five principal classes of antihypertensive drugs
30. Renin system understanding for analysis and treatment of hypertensive patients: A means to qualify the vasoconstrictor elements, diagnose curable renal and adrenal causes, access risk of cardiovascular morbidity, and find the best-fit drug regimen
31. Blood pressure screening, management and control in England: Results from the health survey for England 1994
32. A clinical trial of the effects of dietary patterns on blood pressure
33. Twenty-year follow-up of hemodynamics in essential hypertension during rest and exercise
34. Withdrawal of antihypertensive treatment after two years of blood pressure normalisation in young patients
35. Mineralocorticoid hypertension
36. Liddle's syndrome: Heritable human hypertension caused by mutations in the β-subunit of the epithelial sodium channel
37. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy
38. A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid remediable aldosteronism and human hypertension
39. Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11 β-hydrexysteroid dehydrogenase type 2 gene
40. Influence of diabetes and type of hypertension on the response to antihypertensive treatment
41. Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: Results of the HANE study
42. Single-drug therapy for hypertension in men - A comparison of six antihypertensive agents with placebo
43. 1 blockade and angiotensin converting enzyme inhibition in essential hypertension
44. Phaeochromocytoma
45. High incidence of primary aldosteronism in 199 patients referred with hypertension
46. Potentially high prevalence of primary aldosteronism in a primary-care population